Prognostic impact of EBV serostatus in patients with lymphomas or chronic malignancies undergoing allogeneic HCT

J Styczynski; G Tridello; L Gil; P Ljungman; M Mikulska; KN Ward; C Cordonnier; R de la Camara; D Averbuch; N Knelange; G Socie; P Chevallier; D Blaise; I Yakoub-Agha; E Forcade; Jan Cornelissen; J Maertens; E Petersen; S Nguyen-Quoc; H Veelken; N Schaap; J Passweg; M Michallet; N Fegueux; E Deconinck; N Russell; G Basak; P Bader; S Montoto; N Kroger; S Cesaro

doi:10.1038/s41409-019-0627-9

Prognostic impact of EBV serostatus in patients with lymphomas or chronic malignancies undergoing allogeneic HCT

J Styczynski, G Tridello, L Gil, P Ljungman, M Mikulska, KN Ward, C Cordonnier, R de la Camara, D Averbuch, N Knelange, G Socie, P Chevallier, D Blaise, I Yakoub-Agha, E Forcade, Jan Cornelissen, J Maertens, E Petersen, S Nguyen-Quoc, H VeelkenN Schaap, J Passweg, M Michallet, N Fegueux, E Deconinck, N Russell, G Basak, P Bader, S Montoto, N Kroger, S Cesaro

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

9 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2060-2071
Number of pages	12
Journal	Bone Marrow Transplantation
Volume	54
Issue number	12
DOIs	https://doi.org/10.1038/s41409-019-0627-9
Publication status	Published - 2019

Research programs

EMC OR-01

Access to Document

10.1038/s41409-019-0627-9

Cite this

Styczynski, J., Tridello, G., Gil, L., Ljungman, P., Mikulska, M., Ward, KN., Cordonnier, C., de la Camara, R., Averbuch, D., Knelange, N., Socie, G., Chevallier, P., Blaise, D., Yakoub-Agha, I., Forcade, E., Cornelissen, J., Maertens, J., Petersen, E., Nguyen-Quoc, S., ... Cesaro, S. (2019). Prognostic impact of EBV serostatus in patients with lymphomas or chronic malignancies undergoing allogeneic HCT. Bone Marrow Transplantation, 54(12), 2060-2071. https://doi.org/10.1038/s41409-019-0627-9

@article{7a2370f0afa949579b4716d6b4e6e327,

title = "Prognostic impact of EBV serostatus in patients with lymphomas or chronic malignancies undergoing allogeneic HCT",

author = "J Styczynski and G Tridello and L Gil and P Ljungman and M Mikulska and KN Ward and C Cordonnier and \{de la Camara\}, R and D Averbuch and N Knelange and G Socie and P Chevallier and D Blaise and I Yakoub-Agha and E Forcade and Jan Cornelissen and J Maertens and E Petersen and S Nguyen-Quoc and H Veelken and N Schaap and J Passweg and M Michallet and N Fegueux and E Deconinck and N Russell and G Basak and P Bader and S Montoto and N Kroger and S Cesaro",

year = "2019",

doi = "10.1038/s41409-019-0627-9",

language = "Undefined/Unknown",

volume = "54",

pages = "2060--2071",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Springer Nature",

number = "12",

}

Styczynski, J, Tridello, G, Gil, L, Ljungman, P, Mikulska, M, Ward, KN, Cordonnier, C, de la Camara, R, Averbuch, D, Knelange, N, Socie, G, Chevallier, P, Blaise, D, Yakoub-Agha, I, Forcade, E, Cornelissen, J, Maertens, J, Petersen, E, Nguyen-Quoc, S, Veelken, H, Schaap, N, Passweg, J, Michallet, M, Fegueux, N, Deconinck, E, Russell, N, Basak, G, Bader, P, Montoto, S, Kroger, N & Cesaro, S 2019, 'Prognostic impact of EBV serostatus in patients with lymphomas or chronic malignancies undergoing allogeneic HCT', Bone Marrow Transplantation, vol. 54, no. 12, pp. 2060-2071. https://doi.org/10.1038/s41409-019-0627-9

TY - JOUR

T1 - Prognostic impact of EBV serostatus in patients with lymphomas or chronic malignancies undergoing allogeneic HCT

AU - Styczynski, J

AU - Tridello, G

AU - Gil, L

AU - Ljungman, P

AU - Mikulska, M

AU - Ward, KN

AU - Cordonnier, C

AU - de la Camara, R

AU - Averbuch, D

AU - Knelange, N

AU - Socie, G

AU - Chevallier, P

AU - Blaise, D

AU - Yakoub-Agha, I

AU - Forcade, E

AU - Cornelissen, Jan

AU - Maertens, J

AU - Petersen, E

AU - Nguyen-Quoc, S

AU - Veelken, H

AU - Schaap, N

AU - Passweg, J

AU - Michallet, M

AU - Fegueux, N

AU - Deconinck, E

AU - Russell, N

AU - Basak, G

AU - Bader, P

AU - Montoto, S

AU - Kroger, N

AU - Cesaro, S

PY - 2019

Y1 - 2019

U2 - 10.1038/s41409-019-0627-9

DO - 10.1038/s41409-019-0627-9

M3 - Article

C2 - 31363166

SN - 0268-3369

VL - 54

SP - 2060

EP - 2071

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

IS - 12

ER -